Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.

Silk Road Medical (SILK) Stock Forecast & Price Target

Silk Road Medical logo
Get the Latest News and Ratings for SILK and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Silk Road Medical and its competitors.

Sign Up

SILK Analyst Ratings Over Time

TypeCurrent Forecast
11/22/23 to 11/21/24
1 Month Ago
10/23/23 to 10/22/24
3 Months Ago
8/24/23 to 8/23/24
1 Year Ago
11/22/22 to 11/22/23
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
0 Buy rating(s)
0 Buy rating(s)
1 Buy rating(s)
1 Buy rating(s)
Hold
4 Hold rating(s)
5 Hold rating(s)
7 Hold rating(s)
7 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
2 Sell rating(s)
2 Sell rating(s)
Consensus Price Target$24.00$24.00$21.50$24.60
Forecasted Upside-12.70% Downside-12.70% Downside-21.07% Downside194.61% Upside
Consensus Rating
Reduce
Reduce
Reduce
Reduce

SILK Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

SILK Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Silk Road Medical Stock vs. The Competition

TypeSilk Road MedicalMedical CompaniesS&P 500
Consensus Rating Score
1.80
2.80
2.50
Consensus RatingReduceModerate BuyModerate Buy
Predicted Upside-12.70% Downside26,906.41% Upside9.81% Upside
News Sentiment Rating
Neutral News

See Recent SILK News
Neutral News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
7/17/2024Stifel Nicolaus
4 of 5 stars
 Reiterated RatingBuy ➝ Hold$23.00 ➝ $27.50+1.59%
7/11/2024Argus
2 of 5 stars
S. Silver
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Sell
6/18/2024Lake Street Capital
3 of 5 stars
F. Takkinen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Hold$28.00 ➝ $27.50+2.31%
5/1/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$19.00 ➝ $21.00+9.78%
5/1/2024Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$18.00 ➝ $20.00+9.11%
10/24/2023Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeUnderperform ➝ Peer Perform
10/11/2023CL King
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Neutral
10/11/2023Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Sell$35.00 ➝ $8.00-42.82%
10/11/2023B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
N. Chatterji
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral$54.00 ➝ $14.00+0.07%
9/5/2023Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform$30.00+61.29%
7/12/2023Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Underperform$51.00 ➝ $28.00-14.24%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 06:27 AM ET.


SILK Forecast - Frequently Asked Questions

According to the research reports of 5 Wall Street equities research analysts, the average twelve-month stock price forecast for Silk Road Medical is $24.00, with a high forecast of $27.50 and a low forecast of $20.00.

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Silk Road Medical in the last twelve months. There is currently 1 sell rating and 4 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "reduce" SILK shares.

According to analysts, Silk Road Medical's stock has a predicted downside of -12.70% based on their 12-month stock forecasts.

Analysts like Silk Road Medical less than other "medical" companies. The consensus rating for Silk Road Medical is Reduce while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how SILK compares to other companies.


This page (NASDAQ:SILK) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners